Triptans do not Increase Risk of Stroke in Migraine
Abstract
The incidence of stroke, cardiovascular events, and death among 63,575 patients with migraine was compared in those prescribed a triptan (13,664, 21.5%), non-triptan-treated, and matched nonmigraine control subjects (77,239) identified from the General Practice Research Database by researchers at the Institute of Neurology, University College, London, UK, and Pfizer Inc, New York, NY.
DOI: https://doi.org/10.15844/pedneurbriefs-18-3-2 | Journal eISSN: 2166-6482
Language: English
Page range: 18 - 19
Published on: Mar 1, 2004
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2004 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.